ETH-LAD

ETH-LAD is a semisynthetic psychedelic of the lysergamide class and a structural analog of LSD, distinguished by the substitution of an ethyl group in place of the methyl group at the nitrogen of the nor-lysergic acid skeleton. Its human use was first documented by Alexander Shulgin in his 1997 book TiHKAL. It is noted for producing modified visual distortion relative to LSD and has been sold as a grey-market research chemical.

Also known as: N-ethyl-nor-lsd

Classification

Chemical: Lysergamide
Psychoactive: Psychedelic
Tag: Hallucinogen
Tag: Research-Chemical

Effects

Nausea
Pupil Dilation
Spontaneous Tactile Sensations
Stimulation
Dilated Pupils
Analysis Enhancement
Conceptual Thinking
Delusion
Emotion Enhancement
Feelings Of Interdependent Opposites
Immersion Enhancement
Bodily Control Enhancement
Tactile Enhancement
Hallucinations
After Images
Color Shifting
Diffraction

Routes of Administration

Oral

Dosage

Heavy: 200 ug
Light: 20 – 60 µg
Common: 60 – 100 µg
Strong: 100 – 200 µg
Threshold: 20-30 ug

Duration

Onset: 0.33-0.67 h
Comeup: 0.75-1.5 h
Peak: 4-6 h
Offset: 2-4 h
After Effects: 8-48 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu